FIELD: medicine.
SUBSTANCE: for prevention of a progressing autoimmune process accompanying a nodular goiter surgery. That is ensured by the introduction of a glucocorticoid suspension between external and internal leaves of a IV cervical fascia when excising a thyroid gland. 1 ml of the suspension contains 25 mg of hydrocortisone acetate and 5 mg of lidocaine hydrochloride. The introduction is carried out at 1 ml of the suspension per 3 cm of thyroid tissue.
EFFECT: method allows to provide the prevention of the progressing autoimmune process in a preserved thyroid tissue and to reduce the risk of development of postoperative hypothyroidism due to the introduction of a preparation so that to avoid an additional damage of the gland tissue, and due to the inhibition of development of lymphoid infiltration and fibrosis without mitosostatic effect on the thyroid tissue.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR AUTOTRANSPLANTING THYROID GLAND TISSUES WHEN CARRYING OUT SUBTOTAL THYROID GLAND RESECTION ON THE OCCASION OF BILATERAL MULTINODULAR GOITER | 2006 |
|
RU2319458C1 |
METHOD FOR SURGICAL MANAGEMENT OF FOLLICULAR THYROID CANCER | 2013 |
|
RU2531467C1 |
METHOD FOR SURGICAL TREATMENT OF DIFFUSE TOXIC GOITER | 2005 |
|
RU2281040C1 |
METHOD FOR PREVENTION OF RECURRENT LARYNGEAL NERVE DAMAGE IN POSTOPERATIVE PERIOD DURING HEMITHYROIDECTOMY OR THYROIDECTOMY | 2023 |
|
RU2820260C1 |
METHOD FOR SURGICAL TREATMENT OF DIFFUSE TOXIC GOITER | 2006 |
|
RU2294704C1 |
METHOD FOR SURGICAL TREATMENT OF THYROID DISEASES | 2004 |
|
RU2257857C1 |
METHOD OF TREATING HASHIMOTO DISEASE | 2009 |
|
RU2410089C1 |
METHOD OF TREATMENT OF TEMPORAL POSTOPERATIVE PARESIS OF RECURRENT LARYNGEAL NERVE IN EXTENSIVE THYROID GLAND SURGERY | 2007 |
|
RU2348403C1 |
METHOD FOR TWO-STAGE TREATMENT OF NODULAR TOXIC GOITER | 2023 |
|
RU2820877C1 |
METHOD TO FORM A STUMP OF THYROID GLAND AT SURGICAL TREATMENT OF DIFFUSE TOXIC GOITER | 1994 |
|
RU2113176C1 |
Authors
Dates
2011-01-27—Published
2009-10-16—Filed